Cancer Prevention Network
CPN Trial Listings
Open and Active CPN Trials
- MAY04-4-01 "Randomized, Double-Blinded Phase II Trial of Esomeprazole Versus Esomeprazole Plus Two Doses of Aspirin in Barrett's Esophagus Patients"
- MAY06-8-01 "Phase IIb Trial of Myo-inositol in Smokers with Bronchial Dysplasia"
Closed/Completed CPN Trials
- MAY07-9-01 "Single-Dose Phase 0 Exploratory Pharmacokinetic Clinical Trial Comparing Five Oral Formulations of SR13668, an Orally Active AKT Pathway Inhibitor"
- MAY03-1-02 "Randomized Phase IIb Trial of Sulindac in Smokers With Bronchial Dysplasia"
- MAY03-1-03 "Randomized Phase II Trial of Atorvastatin, Raftilose Synergy 1, and Sulindac Among Patients at Increased Risk for Sporadic Colorectal Neoplasia"
- MAY03-1-BIO "Bioequivalency Study of Sulindac in Capsule vs. Tablet Formulations"
CPN Trials for which concepts are now being developed
- Hepatobiliary Cancer
- Breast Cancer
- Colon Cancer
For more information, contact CPN's Operations Office.
The mission of the Cancer Prevention Network is to organize, promote, and conduct cancer prevention research through a coordinated multidisciplinary network of dedicated investigators and study personnel.
